Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Abdominal Radiology
Erschienen in: Abdominal Radiology 6/2011

01.12.2011

The current role of minimally invasive therapies in the management of liver tumors

verfasst von: Hansjörg Rempp, Andreas Boss, Thomas Helmberger, Philippe Pereira

Erschienen in: Abdominal Radiology | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Abstract

This is a review of minimally invasive therapy options for liver tumors, such as highly focused ultrasound, microwave ablation, and irreversible electroporation, as well as new aspects of radiofrequency ablation. Radiofrequency ablation is recommended for patients with early-stage HCC with up to 3 lesions with a tumor diameter within 3 cm and for patients with non-resectable liver metastasis. Indications and contraindications to treatment are designated, and different modalities for image-based therapy guidance are compared. Options for therapy monitoring and controlling are reviewed, namely intraprocedural tools, imaging and functional parameters and their evolution during therapy. Prevention and control of local recurrences is discussed. We also present a short review of current clinical results in treating liver metastasis and primary liver tumors.
Literatur
1.
2.
3.
O’Dwyer PJ, Stevenson JP, Haller DG, et al. (2001) Follow-up of stage B and C colorectal cancer in the United States and France. Semin Oncol 28:45–49PubMed
4.
Iyer RB, Silverman PM, DuBrow RA, et al. (2002) Imaging in the diagnosis, staging, and follow-up of colorectal cancer. AJR Am J Roentgenol 179:3–13PubMed
5.
Johns LE, Houlston RS (2001) A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol 96:2992–3003PubMedCrossRef
6.
Ruers TJ, Joosten J, Jager GJ, et al. (2001) Long-term results of treating hepatic colorectal metastases with cryosurgery. Br J Surg 88:844–849PubMedCrossRef
7.
Jessup JM, McGinnis LS, Steele GDJr, et al. (1996) The National Cancer Data Base. Report on colon cancer. Cancer 78:918–926PubMedCrossRef
8.
Yoon SS, Tanabe KK (1998) Multidisciplinary management of metastatic colorectal cancer. Surg Oncol 7:197–207PubMedCrossRef
9.
Wanebo HJ, Semoglou C, Attiyeh F, et al. (1978) Surgical management of patients with primary operable colorectal cancer and synchronous liver metastases. Am J Surg 135:81–85PubMedCrossRef
10.
Wilson SM, Adson MA (1976) Surgical treatment of hepatic metastases from colorectal cancers. Arch Surg 111:330–334PubMed
11.
Wagner JS, Adson MA, Van Heerden JA, et al. (1984) The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg 199:502–508PubMedCrossRef
12.
Scheele J, Stangl R, Altendorf-Hofmann A (1990) Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 77:1241–1246PubMedCrossRef
13.
Lee WS, Yun SH, Chun HK, et al. (2008) Clinical outcomes of hepatic resection and radiofrequency ablation in patients with solitary colorectal liver metastasis. J Clin Gastroenterol 42:945–949PubMedCrossRef
14.
Aloia TA, Vauthey JN, Loyer EM, et al. (2006) Solitary colorectal liver metastasis: resection determines outcome. Arch Surg 141:460–466 (discussion 466–467)PubMedCrossRef
15.
Simmonds PC, Primrose JN, Colquitt JL, et al. (2006) Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 94:982–999PubMedCrossRef
16.
de Baere T, Elias D, Dromain C, et al. (2000) Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR Am J Roentgenol 175:1619–1625PubMed
17.
Ott R, Wein A, Hohenberger W (2001) Liver metastases—primary or multimodal therapy? Chirurg 72:887–897PubMedCrossRef
18.
Mulier S, Ni Y, Jamart J, et al. (2008) Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? Ann Surg Oncol 15:144–157PubMedCrossRef
19.
Llovet JM (2005) Updated treatment approach to hepatocellular carcinoma. J Gastroenterol 40:225–235PubMedCrossRef
20.
21.
Kudo M, Okanoue T (2007) Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology. Oncology 72(suppl 1):2–15PubMedCrossRef
22.
Kudo M (2010) Radiofrequency ablation for hepatocellular carcinoma: updated review in 2010. Oncology 78(suppl 1):113–124PubMedCrossRef
23.
Ryder SD (2003) Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut 52(suppl 3):iii1–iii8PubMed
24.
Bruix J, Sherman M, Llovet JM, et al. (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421–430PubMedCrossRef
25.
Lin SM, Lin CJ, Lin CC, et al. (2004) Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm. Gastroenterology 127:1714–1723PubMedCrossRef
26.
Lin SM, Lin CJ, Lin CC, et al. (2005) Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 54:1151–1156PubMedCrossRef
27.
Shiina S, Teratani T, Obi S, et al. (2005) A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 129:122–130PubMedCrossRef
28.
Orlando A, Leandro G, Olivo M, et al. (2009) Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: meta-analysis of randomized controlled trials. Am J Gastroenterol 104:514–524PubMedCrossRef
29.
Brunello F, Veltri A, Carucci P, et al. (2008) Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: a randomized controlled trial. Scand J Gastroenterol 43:727–735PubMedCrossRef
30.
Cho YK, Kim JK, Kim MY, et al. (2009) Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology 49:453–459PubMedCrossRef
31.
Bouza C, Lopez-Cuadrado T, Alcazar R, et al. (2009) Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma. BMC Gastroenterol 9:31PubMedCrossRef
32.
ter Haar G, Rivens I, Chen L, et al. (1991) High intensity focused ultrasound for the treatment of rat tumours. Phys Med Biol 36:1495–1501PubMedCrossRef
33.
Chen L, Rivens I, ter Haar G, et al. (1993) Histological changes in rat liver tumours treated with high-intensity focused ultrasound. Ultrasound Med Biol 19:67–74PubMedCrossRef
34.
McDannold N, Tempany CM, Fennessy FM, et al. (2006) Uterine leiomyomas: MR imaging-based thermometry and thermal dosimetry during focused ultrasound thermal ablation. Radiology 240:263–272PubMedCrossRef
35.
Madersbacher S, Schatzl G, Djavan B, et al. (2000) Long-term outcome of transrectal high-intensity focused ultrasound therapy for benign prostatic hyperplasia. Eur Urol 37:687–694PubMedCrossRef
36.
Gelet A, Chapelon JY, Bouvier R, et al. (1996) Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience. Eur Urol 29:174–183PubMed
37.
Wu F, Wang ZB, Chen WZ, et al. (2005) Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization. Radiology 235:659–667PubMedCrossRef
38.
Li YY, Sha WH, Zhou YJ, et al. (2007) Short and long term efficacy of high intensity focused ultrasound therapy for advanced hepatocellular carcinoma. J Gastroenterol Hepatol 22:2148–2154PubMedCrossRef
39.
Zhang L, Zhu H, Jin C, et al. (2009) High-intensity focused ultrasound (HIFU): effective and safe therapy for hepatocellular carcinoma adjacent to major hepatic veins. Eur Radiol 19:437–445PubMedCrossRef
40.
Dong B, Liang P, Yu X, et al. (2003) Percutaneous sonographically guided microwave coagulation therapy for hepatocellular carcinoma: results in 234 patients. AJR Am J Roentgenol 180:1547–1555PubMed
41.
Shibata T, Iimuro Y, Yamamoto Y, et al. (2002) Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology 223:331–337PubMedCrossRef
42.
Martin RC, Scoggins CR, McMasters KM (2010) Safety and efficacy of microwave ablation of hepatic tumors: a prospective review of a 5-year experience. Ann Surg Oncol 17:171–178PubMedCrossRef
43.
Liang P, Wang Y, Yu X, et al. (2009) Malignant liver tumors: treatment with percutaneous microwave ablation—complications among cohort of 1136 patients. Radiology 251:933–940PubMedCrossRef
44.
Dohi M, Harada J, Mogami T, et al. (2003) MR-guided percutaneous cryotherapy of malignant liver tumor under horizontal-magnetic open system: initial experience. J Hepatobiliary Pancreat Surg 10:360–365PubMedCrossRef
45.
Vogl TJ, Straub R, Eichler K, et al. (2002) Malignant liver tumors treated with MR imaging-guided laser-induced thermotherapy: experience with complications in 899 patients (2, 520 lesions). Radiology 225:367–377PubMedCrossRef
46.
Silverman SG, Tuncali K, Adams DF, et al. (2000) MR imaging-guided percutaneous cryotherapy of liver tumors: initial experience. Radiology 217:657–664PubMed
47.
Silverman SG, Tuncali K, Adams DF (2000) MR imaging-guided percutaneous cryotherapy of liver tumors: initial experience. Radiology 217:654–667
48.
McCarthy T, Kuhn JA (1998) Cryotherapy for liver tumours. Oncology 12:979–993
49.
Davalos RV, Mir IL, Rubinsky B (2005) Tissue ablation with irreversible electroporation. Ann Biomed Eng 33:223–231PubMedCrossRef
50.
Miller L, Leor J, Rubinsky B (2005) Cancer cells ablation with irreversible electroporation. Technol Cancer Res Treat 4:699–705PubMed
51.
Edd JF, Horowitz L, Davalos RV, et al. (2006) In vivo results of a new focal tissue ablation technique: irreversible electroporation. IEEE Trans Biomed Eng 53:1409–1415PubMedCrossRef
52.
Lee EW, Loh CT, Kee ST (2007) Imaging guided percutaneous irreversible electroporation: ultrasound and immunohistological correlation. Technol Cancer Res Treat 6:287–294PubMed
53.
Onik G, Mikus P, Rubinsky B (2007) Irreversible electroporation: implications for prostate ablation. Technol Cancer Res Treat 6:295–300PubMed
54.
Mali B, Jarm T, Corovic S, et al. (2008) The effect of electroporation pulses on functioning of the heart. Med Biol Eng Comput 46:745–757PubMedCrossRef
55.
Pereira PL, Trubenbach J, Schenk M, et al. (2004) Radiofrequency ablation: in vivo comparison of four commercially available devices in pig livers. Radiology 232:482–490PubMedCrossRef
56.
Clasen S, Schmidt D, Boss A, et al. (2006) Multipolar radiofrequency ablation with internally cooled electrodes: experimental study in ex vivo bovine liver with mathematic modeling. Radiology 238:881–890PubMedCrossRef
57.
Rhim H, Goldberg SN, Dodd GD 3rd, et al. (2001) Essential techniques for successful radio-frequency thermal ablation of malignant hepatic tumors. Radiographics 21(Spec No):S17–S35 (discussion S36–19)PubMed
58.
McGahan JP, Gu WZ, Brock JM, et al. (1996) Hepatic ablation using bipolar radiofrequency electrocautery. Acad Radiol 3:418–422PubMedCrossRef
59.
Clasen S, Schmidt D, Dietz K, et al. (2007) Bipolar radiofrequency ablation using internally cooled electrodes in ex vivo bovine liver: prediction of coagulation volume from applied energy. Invest Radiol 42:29–36PubMedCrossRef
60.
de Baere T, Denys A, Wood BJ, et al. (2001) Radiofrequency liver ablation: experimental comparative study of water-cooled versus expandable systems. AJR Am J Roentgenol 176:187–192PubMed
61.
Goldberg SN, Gazelle GS, Dawson SL, et al. (1995) Tissue ablation with radiofrequency using multiprobe arrays. Acad Radiol 2:670–674PubMedCrossRef
62.
Solazzo SA, Ahmed M, Liu Z, et al. (2007) High-power generator for radiofrequency ablation: larger electrodes and pulsing algorithms in bovine ex vivo and porcine in vivo settings. Radiology 242:743–750PubMedCrossRef
63.
Goldberg SN, Stein MC, Gazelle GS, et al. (1999) Percutaneous radiofrequency tissue ablation: optimization of pulsed-radiofrequency technique to increase coagulation necrosis. J Vasc Interv Radiol 10:907–916PubMedCrossRef
64.
Schmidt D, Trubenbach J, Brieger J, et al. (2003) Automated saline-enhanced radiofrequency thermal ablation: initial results in ex vivo bovine livers. AJR Am J Roentgenol 180:163–165PubMed
65.
Livraghi T, Goldberg SN, Monti F, et al. (1997) Saline-enhanced radio-frequency tissue ablation in the treatment of liver metastases. Radiology 202:205–210PubMed
66.
Goldberg SN, Ahmed M, Gazelle GS, et al. (2001) Radio-frequency thermal ablation with NaCl solution injection: effect of electrical conductivity on tissue heating and coagulation-phantom and porcine liver study. Radiology 219:157–165PubMed
67.
Goldberg SN, Solbiati L, Hahn PF, et al. (1998) Large-volume tissue ablation with radio frequency by using a clustered, internally cooled electrode technique: laboratory and clinical experience in liver metastases. Radiology 209:371–379PubMed
68.
Lorentzen T (1996) A cooled needle electrode for radiofrequency tissue ablation: thermodynamic aspects of improved performance compared with conventional needle design. Acad Radiol 3:556–563PubMedCrossRef
69.
Rempp H, Voigtländer M, Clasen S, et al. (2009) Increased ablation zones using a cryo-based internally cooled bipolar RF applicator in ex vivo bovine liver. Invest Radiol 44:763–768PubMedCrossRef
70.
Hines-Peralta A, Hollander CY, Solazzo S, et al. (2004) Hybrid radiofrequency and cryoablation device: preliminary results in an animal model. J Vasc Interv Radiol 15:1111–1120PubMed
71.
Leyendecker JR, Dodd GD 3rd, Halff GA, et al. (2002) Sonographically observed echogenic response during intraoperative radiofrequency ablation of cirrhotic livers: pathologic correlation. AJR Am J Roentgenol 178:1147–1151PubMed
72.
Choi D, Lim HK, Kim SH, et al. (2000) Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results. Radiology 217:558–563PubMed
73.
Solbiati L, Goldberg SN, Ierace T, et al. (1999) Radio-frequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent—early experience. Radiology 211:643–649PubMed
74.
Kim MJ, Kim JH, Chung JJ, et al. (2003) Focal hepatic lesions: detection and characterization with combination gadolinium- and superparamagnetic iron oxide-enhanced. MR Imaging 228:719–726
75.
Bartolozzi C, Donati F, Cioni D, et al. (2004) Detection of colorectal liver metastases: a prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT. Eur Radiol 14:14–20PubMedCrossRef
76.
Kim YK, Lee JM, Kim CS (2004) Gadobenate dimeglumine-enhanced liver MR imaging: value of dynamic and delayed imaging for the characterization and detection of focal liver lesions. Eur Radiol 14:5–13PubMedCrossRef
77.
Goldberg SN, Grassi CJ, Cardella JF, et al. (2005) Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 235:728–739PubMedCrossRef
78.
Graham SJ, Stanisz GJ, Kecojevic A, et al. (1999) Analysis of changes in MR properties of tissues after heat treatment. Magn Reson Med 42:1061–1071PubMedCrossRef
79.
Kierans AS, Elazzazi M, Braga L, et al. (2010) Thermoablative treatments for malignant liver lesions: 10-year experience of MRI appearances of treatment response. AJR Am J Roentgenol 194:523–529PubMedCrossRef
80.
Boss A, Graf H, Muller-Bierl B, et al. (2005) Magnetic susceptibility effects on the accuracy of MR temperature monitoring by the proton resonance frequency method. J Magn Reson Imaging 22:813–820PubMedCrossRef
81.
Quesson B, de Zwart JA, Moonen CT (2000) Magnetic resonance temperature imaging for guidance of thermotherapy. J Magn Reson Imaging 12:525–533PubMedCrossRef
82.
Lepetit-Coiffe M, Laumonier H, Seror O, et al. (2010) Real-time monitoring of radiofrequency ablation of liver tumors using thermal-dose calculation by MR temperature imaging: initial results in nine patients, including follow-up. Eur Radiol 20:193–201PubMedCrossRef
83.
Rempp H, Clasen S, Boss A, et al. (2009) Prediction of cell necrosis with sequential temperature mapping after radiofrequency ablation. J Magn Reson Imaging 30:631–639PubMedCrossRef
84.
Ng KK, Poon RT, Lo CM, et al. (2008) Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma. J Gastrointest Surg 12:183–191PubMedCrossRef
85.
Rhim H, Dodd GD 3rd, Chintapalli KN, et al. (2004) Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications. Radiographics 24:41–52PubMedCrossRef
86.
Llovet JM, Vilana R, Bru C, et al. (2001) Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 33:1124–1129PubMedCrossRef
87.
Choi H, Loyer EM, DuBrow RA, et al. (2001) Radio-frequency ablation of liver tumors: assessment of therapeutic response and complications. Radiographics 21(Spec No):S41–S54PubMed
88.
Livraghi T, Solbiati L, Meloni MF, et al. (2003) Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 226:441–451PubMedCrossRef
89.
Chen MS, Li JQ, Zheng Y, et al. (2006) A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 243:321–328PubMedCrossRef
90.
Lu MD, Kuang M, Liang LJ, et al. (2006) Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial. Zhonghua Yi Xue Za Zhi 86:801–805PubMed
91.
Ogihara M, Wong LL, Machi J (2005) Radiofrequency ablation versus surgical resection for single nodule hepatocellular carcinoma: long-term outcomes. HPB (Oxford) 7:214–221
92.
Lupo L, Panzera P, Giannelli G, et al. (2007) Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection? HPB (Oxford) 9:429–434
93.
Ueno S, Sakoda M, Kubo F, et al. (2009) Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria. J Hepatobiliary Pancreat Surg 16:359–366PubMedCrossRef
94.
Molinari M, Helton S (2009) Hepatic resection versus radiofrequency ablation for hepatocellular carcinoma in cirrhotic individuals not candidates for liver transplantation: a Markov model decision analysis. Am J Surg 198:396–406PubMedCrossRef
95.
Livraghi T, Meloni F, Di Stasi M, et al. (2008) Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice? Hepatology 47:82–89PubMedCrossRef
96.
Guglielmi A, Ruzzenente A, Valdegamberi A, et al. (2008) Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis. J Gastrointest Surg 12:192–198PubMedCrossRef
97.
Ikai I, Arii S, Okazaki M, et al. (2007) Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan. Hepatol Res 37:676–691PubMedCrossRef
98.
Hasegawa K, Makuuchi M, Takayama T, et al. (2008) Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. J Hepatol 49:589–594PubMedCrossRef
99.
Lencioni RA, Allgaier HP, Cioni D, et al. (2003) Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 228:235–240PubMedCrossRef
100.
Camma C, Di Marco V, Orlando A, et al. (2005) Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study. J Hepatol 42:535–540PubMedCrossRef
101.
Lencioni R, Cioni D, Crocetti L, et al. (2005) Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234:961–967PubMedCrossRef
102.
Lau WY, Leung TW, Yu SC, et al. (2003) Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future. Ann Surg 237:171–179PubMed
103.
Berber E, Tsinberg M, Tellioglu G, et al. (2008) Resection versus laparoscopic radiofrequency thermal ablation of solitary colorectal liver metastasis. J Gastrointest Surg 12:1967–1972PubMedCrossRef
104.
Veltri A, Sacchetto P, Tosetti I, et al. (2008) Radiofrequency ablation of colorectal liver metastases: small size favorably predicts technique effectiveness and survival. Cardiovasc Intervent Radiol 31:948–956PubMedCrossRef
105.
Machi J, Oishi AJ, Sumida K, et al. (2006) Long-term outcome of radiofrequency ablation for unresectable liver metastases from colorectal cancer: evaluation of prognostic factors and effectiveness in first- and second-line management. Cancer J 12:318–326PubMedCrossRef
106.
Gillams AR, Lees WR (2004) Radio-frequency ablation of colorectal liver metastases in 167 patients. Eur Radiol 14:2261–2267PubMedCrossRef
107.
Mulier S, Ruers T, Jamart J, et al. (2008) Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? An update. Dig Surg 25:445–460PubMedCrossRef
108.
Mulier S, Ni Y, Jamart J, et al. (2005) Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 242:158–171PubMedCrossRef
Metadaten
Titel
The current role of minimally invasive therapies in the management of liver tumors
verfasst von
Hansjörg Rempp
Andreas Boss
Thomas Helmberger
Philippe Pereira
Publikationsdatum
01.12.2011
Verlag
Springer-Verlag
Erschienen in
Abdominal Radiology / Ausgabe 6/2011
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-011-9749-2

Weitere Artikel der Ausgabe 6/2011

Abdominal Radiology 6/2011 Zur Ausgabe

OriginalPaper

Precise delineation of ureterocele anatomy: virtual magnetic resonance cystoscopy

OriginalPaper

Arterial therapies of non-colorectal cancer metastases to the liver (from chemoembolization to radioembolization)

Report

Aggressive angiomyxoma of the pelvis and perineum: a case report and review of the literature

OriginalPaper

Gallbladder metastasis: spectrum of imaging findings

OriginalPaper

Peri-intraprocedural imaging: US, CT, and MRI

Report

Diagnosis of a variant of Mayer–Rokitansky–Kuster–Hauser syndrome: useful MRI findings

Neu im Fachgebiet Radiologie

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärztinnen und Psychotherapeuten.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise